|

Rozanolixizumab Clinical Trials

2 actively recruiting trials across 1 location

Also known as: UCB7665

Pipeline

Phase 4: 1Phase 2/3: 1

Top Sponsors

  • UCB Biopharma SRL2

Indications

  • Cancer2
  • Myasthenia Gravis1
  • Generalized Myasthenia Gravis1

Other1 trial

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis
Phase 4

Flower Mound, Texas1 trial

A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis

Mg0006 50574

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.